PMID- 37663228 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230905 IS - 2692-4609 (Electronic) IS - 2692-4609 (Linking) VI - 4 IP - 1 DP - 2024 Apr TI - Morphological change of foveolar-type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case report. PG - e293 LID - 10.1002/deo2.293 [doi] LID - e293 AB - A 37-year-old man with systemic lupus erythematosus underwent esophagogastroduodenoscopy as a screening examination for anemia and bloody stool. A semi-pedunculated edematous lobular polyp of 25 mm in size was detected in the greater curvature of the upper gastric body. At that time, a definitive diagnosis of cancer could not be made based on a biopsy specimen from the lesion. Since the patient was on proton pump inhibitor (PPI) for a long time to prevent peptic ulceration due to prolonged prednisolone administration for systemic lupus erythematosus, we diagnosed the lesion as a PPI-associated hyperplastic polyp and switched lansoprazole to famotidine. Two months later, esophagogastroduodenoscopy revealed that the polyp had decreased in size to 8 mm, whereas the biopsy specimen led to a histological diagnosis of gastric cancer. The polyp was removed by endoscopic submucosal dissection. Immunohistochemistry revealed that the tumor cells were positive for MUC5AC, but negative for MUC2 and MUC6, leading to a final diagnosis of foveolar-type gastric adenocarcinoma. In conclusion, we may suggest that PPI induces reversible morphological changes in foveolar-type gastric adenocarcinoma. Furthermore, short-term follow-up of polypoid lesions should be prepared, considering tumor comorbidity with morphological changes during long-term PPI usage. CI - (c) 2023 The Authors. DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society. FAU - Igarashi, Shohei AU - Igarashi S AUID- ORCID: 0000-0002-0660-7327 AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Hanabata, Norihiro AU - Hanabata N AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Furusawa, Keisuke AU - Furusawa K AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Suto, Shinya AU - Suto S AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Satake, Miwa AU - Satake M AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Shimaya, Koji AU - Shimaya K AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Kanazawa, Kosuke AU - Kanazawa K AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Numao, Hiroshi AU - Numao H AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Munakata, Masaki AU - Munakata M AD - Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan. FAU - Kurotaki, Hidekachi AU - Kurotaki H AD - Department of Pathology Aomori Prefectural Central Hospital Aomori Japan. FAU - Sakuraba, Hirotake AU - Sakuraba H AD - Department of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Aomori Japan. FAU - Yoshida, Shigeaki AU - Yoshida S AD - Aomori Prefectural Hospital Administration Aomori Japan. LA - eng PT - Case Reports DEP - 20230901 PL - Australia TA - DEN Open JT - DEN open JID - 9918317682706676 PMC - PMC10474311 OTO - NOTNLM OT - endoscopic submucosal dissection OT - gastric cancer OT - immunohistochemistry OT - morphology OT - proton pump inhibitor COIS- None. EDAT- 2023/09/04 06:42 MHDA- 2023/09/04 06:43 PMCR- 2023/09/01 CRDT- 2023/09/04 04:56 PHST- 2023/06/07 00:00 [received] PHST- 2023/08/16 00:00 [revised] PHST- 2023/08/19 00:00 [accepted] PHST- 2023/09/04 06:43 [medline] PHST- 2023/09/04 06:42 [pubmed] PHST- 2023/09/04 04:56 [entrez] PHST- 2023/09/01 00:00 [pmc-release] AID - DEO2293 [pii] AID - 10.1002/deo2.293 [doi] PST - epublish SO - DEN Open. 2023 Sep 1;4(1):e293. doi: 10.1002/deo2.293. eCollection 2024 Apr.